Vendor description
This vendor hasn't published their own description yet. It will appear here once they claim this profile and add it from their dashboard.
At a glance
- Qritive provides AI-powered digital pathology solutions for cancer diagnosis,supporting clinical trials with automated tissue analysis and biomarker scoring.
- Coverage: Global · Phase II–III
- Therapeutic focus: Oncology, Pathology, Gastroenterology
- Scale: Small,Medium
Company fit
Best suited for
Oncology pathology biomarker analysis in APAC-based trials
Study fit
Best suited for oncology pathology biomarker analysis in apac-based trials.
Core strengths
- Digital pathology AI
- Cancer biomarker scoring
- APAC presence
Considerations
- Pathology-focused only
- Smaller scale
Key facts
- Category
- AI / Machine Learning
- Geography
- Global
- Studies managed
- 8
- HQ
- Singapore
- Company size
- 50 employees
- Year founded
- 2018